25 stories tagged with #pfizer, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Pfizer"
STAT+: Amid confusion over Pfizer’s emergency penicillin program, newborn is diagnosed with preventable syphilis
Congenital syphilis should be preventable. An Arizona case shows how drug shortages and procedural hurdles are fueling a growing public health crisis.…
Roche Vs. Pfizer: Obesity Week Presentations Deep Dive - What Investors Must Know
Roche vs Pfizer in the booming GLP-1 obesity/T2D market: Phase 2 enicepatide vs berobenatide claims, pipeline strength, and why Roche leads—read now.…
STAT+: Novo underwhelmed by drug it once fought Pfizer for
Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news…
STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide…
Pfizer vs Merck: Chasing High Yield vs Higher Returns
STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA
ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.…
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions…
Pfizer is teaming up with a Chinese biotech on a $10.5 billion cancer drug deal
Innovent Biologics Surges After Signing Up to $10.5 Billion Deal With Pfizer - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer.…
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.…
Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
FDA panel recommends updating covid shots to target XFG strain
XFG, nicknamed “stratus,” carries mutations that could help it partially dodge Covid antibodies.…
BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results
Pfizer's CEO uses AI to make his biggest calls — and 64% of CEOs agree, quietly shifting your portfolio
Why 1 Wall Street Analyst Thinks Pfizer (PFE) Stock Could Soar 38%
What's the Better Dividend Stock Today: AbbVie or Pfizer?
Pfizer’s SWOT analysis: stock navigates patent cliff with new drugs
Pfizer: Reduced TrumpRx/Patent Risks Meet Accretive M&A Efforts - Reiterate Buy
PFE's aggressive M&A and in-house R&D efforts are paying off, with the growth portfolio (newly launched/acquired products) already delivering $3.1B in...…
WATCH: Duffy flips script on Dem senators with pointed questions about their own campaign cash
Transportation Secretary Sean Duffy clashes with Democratic senators over corporate-funded Great American Road Trip as Americans face high gas prices.…
FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer
Compare JNJ vs. PFE: Why Johnson & Johnson’s stability, dividend growth, and buybacks may beat Pfizer’s low valuation and high yield. Read the full analysis here.…
How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise
Form PRE 14A Pfizer For: 19 May
Why Pfizer Stock Still Looks Deeply Undervalued In 2026
FDA leadership shake-up update and what it means for Pfizer: valuation, dividend yield, and Padcev growth.…